3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Observational
2
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Pancreatic Neoplasms
1
Duodenal Neoplasms
1
Bile Duct Neoplasms
1
Interventions
Specimen Handling
613
pembrolizumab
563
Magnetic Resonance Spectroscopy
536
Carboplatin
425
Cisplatin
375
Cyclophosphamide
373
Biopsy
357
Paclitaxel
306
Gemcitabine
303
Nivolumab
300
Radiotherapy
260
Bevacizumab
234
Dexamethasone
209
fludarabine
205
Docetaxel
187
durvalumab
182
atezolizumab
173
Oxaliplatin
172
venetoclax
168
Fluorouracil
166
Rituximab
165
Pemetrexed
163
Capecitabine
158
Doxorubicin
157
Radiation
155
Radiosurgery
148
Etoposide
137
Leucovorin
133
Ipilimumab
133
Lenalidomide
131
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Stents
×
90 days
×
Clear all
NCT06274879
2026-05-26
Ablatio
Insel Gruppe AG, University Hospital Bern
Phase 2
Recruiting
36 enrolled
NCT06630910
2026-03-31
whipple
Theodor Bilharz Research Institute
Phase NA
Completed
48 enrolled